Tüberküloz Dışı Mikobakterilerde İmmünopatogenez
Referanslar
Ratnatunga CN, Lutzky VP, Kupz A, et al. The rise of non-tuberculosis mycobacterial lung disease. Frontiers in Immunology. 2020;11:303. doi:10.3389/fimmu.2020.00303.
Cowman S, van Ingen J, Griffith DE, et al. Non-tuberculous mycobacterial pulmonary disease. European Respiratory Journal. 2019;54(1):1900250. doi:10.1183/13993003.00250-2019.
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clinical Infectious Diseases. 2020;71(4):e1-e36. doi:10.1093/cid/ciaa241.
Shamaei M, Mirsaeidi M. Nontuberculous mycobacteria, macrophages, and host innate immune response. Infection and Immunity. 2021;89(8):e00812-20. doi:10.1128/IAI.00812-20.
Prasla Z, Sutliff RL, Sadikot RT. Macrophage signaling pathways in pulmonary nontuberculous mycobacteria infections. American Journal of Respiratory Cell and Molecular Biology. 2020;63(2):144-151. doi:10.1165/rcmb.2019-0241TR.
Wang Z, Sun X, Lin Y, et al. Stealth in non-tuberculous mycobacteria: clever challengers to the immune system. Microbiological Research. 2025;292:128039. doi:10.1016/j.micres.2024.128039.
Lee JY, Lee MS, Kim DJ, et al. Nucleotide-binding oligomerization domain 2 contributes to limiting growth of Mycobacterium abscessus in the lung of mice by regulating cytokines and nitric oxide production. Frontiers in Immunology. 2017;8:1477. doi:10.3389/fimmu.2017.01477.
Park HE, Lee W, Choi S, et al. Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection. Frontiers in Immunology. 2022;13:931876. doi:10.3389/fimmu.2022.931876.
Silwal P, Kim IS, Jo EK. Autophagy and host defense in nontuberculous mycobacterial infection. Frontiers in Immunology. 2021;12:728742. doi:10.3389/fimmu.2021.728742.
Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Human Genetics. 2020;139(6-7):993-1000. doi:10.1007/s00439-020-02120-y.
Rottman M, Catherinot E, Hochedez P, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infection and Immunity. 2007;75(12):5898-5907. doi:10.1128/IAI.00014-07.
Bernut A, Nguyen-Chi M, Halloum I, et al. Mycobacterium abscessus-induced granuloma formation is strictly dependent on TNF signaling and neutrophil trafficking. PLOS Pathogens. 2016;12(11):e1005986. doi:10.1371/journal.ppat.1005986.
Lim A, Allison C, Price P, et al. Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency. Clinical Immunology. 2010;137(2):296-302. doi:10.1016/j.clim.2010.07.011.
Gramegna A, Lombardi A, Lorè NI, et al. Innate and adaptive lymphocytes in non-tuberculous mycobacteria lung disease: a review. Frontiers in Immunology. 2022;13:927049. doi:10.3389/fimmu.2022.927049.
Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clinics in Chest Medicine. 2015;36(1):91-99. doi:10.1016/j.ccm.2014.11.002.
Lindestam Arlehamn CS, Benson B, Kuan R, et al. T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease. Frontiers in Immunology. 2022;13:1016038. doi:10.3389/fimmu.2022.1016038.
Koh J, Kim S, Kim JY, et al. Immunologic features of nontuberculous mycobacterial pulmonary disease based on spatially resolved whole transcriptomics. BMC Pulmonary Medicine. 2024;24(1):392. doi:10.1186/s12890-024-03207-2.
Alkarni M, Lipman M, Lowe DM. The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease. Annals of Clinical Microbiology and Antimicrobials. 2023;22(1):14. doi:10.1186/s12941-023-00562-6.
Inomata T, Konno S, Nagai K, et al. Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection. PLOS ONE. 2018;13(2):e0190189. doi:10.1371/journal.pone.0190189.
Sweet L, Schorey JS. Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner. Journal of Leukocyte Biology. 2006;80(2):415-423. doi:10.1189/jlb.1205702.
Cebula BR, Rocco JM, Maslow JN, et al. Mycobacterium avium serovars 2 and 8 infections elicit unique activation of the host macrophage immune responses. European Journal of Clinical Microbiology & Infectious Diseases. 2012;31(12):3407-3412. doi:10.1007/s10096-012-1709-4.
Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nature Reviews Microbiology. 2020;18(7):392-407. doi:10.1038/s41579-020-0331-1.
Roux AL, Viljoen A, Bah A, et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biology. 2016;6(11):160185. doi:10.1098/rsob.160185.
Kam JY, Hortle E, Krogman E, et al. Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish. Nature Communications. 2022;13(1):952. doi:10.1038/s41467-022-28638-5.
Szymanski EP, Leung JM, Fowler CJ, et al. Pulmonary nontuberculous mycobacterial infection: a multisystem, multigenic disease. American Journal of Respiratory and Critical Care Medicine. 2015;192(5):618-628. doi:10.1164/rccm.201502-0387OC.
Namkoong H, Holland SM. Host susceptibility to nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine. 2023;44(4):723-730. doi:10.1016/j.ccm.2023.07.002.
Noma K, Mizoguchi Y, Tsumura M, et al. Mendelian susceptibility to mycobacterial diseases: state of the art. Clinical Microbiology and Infection. 2022;28(11):1429-1434. doi:10.1016/j.cmi.2022.03.004.
Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655. doi:10.1182/blood-2011-05-356352.
Calvo KR, Hickstein DD. The spectrum of GATA2 deficiency syndrome. Blood. 2023;141(13):1524-1532. doi:10.1182/blood.2022017764.
Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. New England Journal of Medicine. 2012;367(8):725-734. doi:10.1056/NEJMoa1111160.
Winthrop KL, Chang E, Yamashita S, et al. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerging Infectious Diseases. 2009;15(10):1556-1561. doi:10.3201/eid1510.090310.
Honda JR, Alper S, Bai X, et al. Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections. Current Opinion in Immunology. 2018;54:66-73. doi:10.1016/j.coi.2018.06.001.